No full-text available
To read the full-text of this research,
you can request a copy directly from the author.
Danish approach on swine production with no antibiotics
Abstract
SUMMARY - Those of the Danish swine producers who have the optimum production facilities are still able to produce pigs with a minimum of antibiotics even though they cannot use antibiotic growth promoters any longer. So far the exclusion of antibiotic growth promoters has resulted in an increase in use of antibiotics for treatment. However, approaches such as optimum management, sectionised batch operation, restricted feeding and ground raw cereals together with organic acids have minimized this increase at present. RESUME - "L'approche du Danemark pour une production porcine sans antibiotiques". Les producteurs porcins du Danemark qui ont des installation de production optimales sont encore capables de produire des porcins avec un minimum d'antibiotiques bien qu'ils ne puissent plus désormais utiliser des promoteurs de croissance antibiotiques. Jusqu'à présent l'exclusion des promoteurs de croissance antibiotiques a donné lieu à une augmentation de l'utilisation des antibiotiques comme traitements. Cependant, des approches telles qu'une gestion optimale, une conduite compartimentée des bandes, une alimentation restreinte et des céréales crues moulues accompagnées d'acides organiques, ont présentement minimisé cette augmentation.
... 2000. Το πρό βλημα προέκυψε από την αντίθετη άποψη και επιχειρη ματολογία του κοινού και μερίδας της επιστημονικής κοι νότητας (MAFF 1997b, Hedegaard 2001, ότι από τη συ νεχή χρήση αντιβιοτικών για διατροφικούς σκοπούς στα ζώα αναπτύσσεται ανθεκτικότητα σε στελέχη παθογόνων μικροοργανισμών (Goransson 1997), οι οποίοι δύσκολα μπορούν να αντιμετωπιστούν στη συνέχεια στον άνθρωπο (cross resistance). ...
An effort is made in this article to present the applications of biotechnology as regards the improvement of nutritive value and the development of novel feeds as well as the production of various types of feed additives. With respect to raw materials, quality upgrading by bio technological means has been attempted through lignocellulose breakdown or protein enrichment. In addition, reference is made to bioproteins and feeds derived from transgenic plants, particularly those resistant to herbicides. In turn, reference is made to aminoacids as products of industrial fermentation. Furthermore, various feed additives, products of biotechnology, such as enzymes, antibiotics, probiotics, but also means for depression of methanogenesis in the forestomachs of ruminants, as well as silage agents, like inoculants and enzymes, are commented upon. In certain cases, reference is made to the issue of efficacy of biotechnology products when used in animal nutrition and the subject of feed safety. Finally, because of the need for licensing these products in order to be circulated, reference is made to the provisions of Community legislation governing the marketing of feeds. The article concludes with some thoughts on the future of the sector of application of biotechnology in the case of animal nutrition.
... coli) or other pathogens has surfaced and Lawsonia intracellularis has caused outbreaks in some grower units, but in general, only a few clinical or subclinical diseases have been observed in Denmark. [7,8] Similar observations were reported from Sweden. [2,5] In nursery pigs, the removal of AGP is causing several problems. ...
The use of antibiotic growth promoters has been questioned in Europe for several decades. The concern has mainly been related to the risk of creating antibiotic resistant microorganisms that can be transferred to humans. The ethical justification for feeding antibiotics to “healthy animals” has been debated as well and during the last decade, the growing consumer demand for “green” food products has further intensified the discussion and created the current situation.
La nutrició animal a la Unió Europea (UE) ha estat afectada per vàries crisis, com la de les vaques boges (encefalopatia bovina espongiforme) (BSE), les hormones a la carn, la contaminació per les dioxines, els Organismes Genèticament Modificats (GMO) i l’ús d’antibiòtics com a promotors de creixement (AMGP). Des dels anys 70, la producció animal a la UE ha estat encaminada a buscar regulacions legals per a millorar la seva seguretat i eficàcia. Si més no, durant els últims cinc anys, casos com la BSE i d’altres han col·locat al sector en primera línia de les notícies, la qual cosa ha trencat la confiança dels consumidors en el consum de carn. Aquesta presentació intentarà explicar per què i com la UE està tractant aquests temes i què és el que el sector està fent per recobrar la confiança dels consumidors. La intenció és respondre a algunes qüestions que preocupen al sector, com per exemple: La producció animal europea, és menys segura que les altres? Per què les regulacions legals són més exigents per a nutrició animal que per als humans? El sector s’està preguntant si aquesta crisi pot produir un nou model europeu de producció animal. Finalment, l’actual sistema de ramaderia s’haurà de discutir: quantitat o qualitat.
ResearchGate has not been able to resolve any references for this publication.